Andrew Aromando, Chief Business Officer: Oncolytics Biotech ONCY Buy · Filed 02/13

Trade details

Type: Insider buy
Amount: $25,456
Shares · price: 29,600 sh · $0.86 a share
Held after: 55,100 sh
Stock: Oncolytics Biotech ONCY
Person: Andrew AromandoChief Business Officer
Trade date: 26/02/11
Filed: 26/02/13
Days to filing: 2 days

First buy since 2023

Insiders buying this week: 9 insiders
Holding change: +116.1%

Oncolytics Biotech trades, last 26 weeks

What else happened in Oncolytics Biotech around then

Filed or reported within 30 days of the trade day · 01/12~03/13

Andrew Aromando's recent trades

No other trades yet.